{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:21:41Z","timestamp":1793020901450,"version":"4.5.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K16663"],"award-info":[{"award-number":["22K16663"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-026-02314-x","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:36:20Z","timestamp":1777880180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Quantitative BRAF p.V600E mutation monitoring in cerebrospinal fluid cell-free DNA reflects therapeutic response to BRAF\/MEK inhibitors in papillary craniopharyngioma: a report of two cases"],"prefix":"10.1186","volume":"14","author":[{"given":"Hirotaka","family":"Fudaba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Yanagida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumpei","family":"Takao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouhei","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Matsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutomo","family":"Momii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Anan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Etoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Fujiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"2314_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1056\/NEJMoa2213329","volume":"389","author":"PK Brastianos","year":"2023","unstructured":"Brastianos PK et al (2023) BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas. N Engl J Med 389:118\u2013126. https:\/\/doi.org\/10.1056\/NEJMoa2213329","journal-title":"N Engl J Med"},{"key":"2314_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ng.2868","volume":"46","author":"PK Brastianos","year":"2014","unstructured":"Brastianos PK et al (2014) Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet 46:161\u2013165. https:\/\/doi.org\/10.1038\/ng.2868","journal-title":"Nat Genet"},{"key":"2314_CR3","doi-asserted-by":"publisher","first-page":"8839","DOI":"10.1038\/ncomms9839","volume":"6","author":"L De Mattos-Arruda","year":"2015","unstructured":"De Mattos-Arruda L et al (2015) Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. Nat Commun 6:8839. https:\/\/doi.org\/10.1038\/ncomms9839","journal-title":"Nat Commun"},{"key":"2314_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41698-024-00535-8","volume":"8","author":"C Arthur","year":"2024","unstructured":"Arthur C et al (2024) Liquid biopsy guides successful molecular targeted therapy of an inoperable pediatric brainstem neoplasm. NPJ Precis Oncol 8:44. https:\/\/doi.org\/10.1038\/s41698-024-00535-8","journal-title":"NPJ Precis Oncol"},{"key":"2314_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-024-02842-7","volume":"149","author":"S Madlener","year":"2025","unstructured":"Madlener S et al (2025) Detection of H3F3A K27M or BRAF V600E in liquid biopsies of brain tumor patients as diagnostic and monitoring biomarker: impact of tumor localization and sampling method. Acta Neuropathol 149:5. https:\/\/doi.org\/10.1007\/s00401-024-02842-7","journal-title":"Acta Neuropathol"},{"key":"2314_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/genes16030275","author":"T Iwai","year":"2025","unstructured":"Iwai T et al (2025) Clinical Implications of Cell-Free DNA in Managing BRAF V600E Mutation-Positive Colorectal Cancer. Genes (Basel) https:\/\/doi.org\/10.3390\/genes16030275","journal-title":"Genes (Basel)"},{"key":"2314_CR7","unstructured":"Yanagida M et al Dramatic Response to BRAF\/MEK Inhibitor Therapy in a Case of BRAFV600E-Mutant Papillary Craniopharyngioma. Japanese J Neurosurg (in press)."},{"key":"2314_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.annonc.2023.02.016","volume":"34","author":"J Ros","year":"2023","unstructured":"Ros J et al (2023) Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments. Ann Oncol 34:543\u2013552. https:\/\/doi.org\/10.1016\/j.annonc.2023.02.016","journal-title":"Ann Oncol"},{"key":"2314_CR9","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S1470-2045(25)00139-1","volume":"26","author":"MM Syeda","year":"2025","unstructured":"Syeda MM et al (2025) Clinical validation of droplet digital PCR assays in detecting BRAF(V600)-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD): a biomarker analysis from a double-blind, randomised phase 3 trial. Lancet Oncol 26:641\u2013653. https:\/\/doi.org\/10.1016\/S1470-2045(25)00139-1","journal-title":"Lancet Oncol"},{"key":"2314_CR10","doi-asserted-by":"publisher","first-page":"5480","DOI":"10.1158\/1078-0432.Ccr-16-0613","volume":"22","author":"L Xi","year":"2016","unstructured":"Xi L et al (2016) Circulating tumor DNA as an early indicator of response to T-cell transfer immunotherapy in metastatic melanoma. Clin Cancer Res 22:5480\u20135486. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-16-0613","journal-title":"Clin Cancer Res"},{"key":"2314_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26020861","author":"C Martinez-Vila","year":"2025","unstructured":"Martinez-Vila C et al (2025) Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma. Int J Mol Sci https:\/\/doi.org\/10.3390\/ijms26020861","journal-title":"Int J Mol Sci"},{"key":"2314_CR12","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1093\/neuonc\/noad032","volume":"25","author":"M Kojic","year":"2023","unstructured":"Kojic M et al (2023) Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening. Neuro Oncol 25:1507\u20131517. https:\/\/doi.org\/10.1093\/neuonc\/noad032","journal-title":"Neuro Oncol"},{"key":"2314_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-025-02880-9","volume":"149","author":"G Dwarshuis","year":"2025","unstructured":"Dwarshuis G et al (2025) Liquid biopsies for the monitoring of gliomas and brain metastases in adults. Acta Neuropathol 149:37. https:\/\/doi.org\/10.1007\/s00401-025-02880-9","journal-title":"Acta Neuropathol"},{"key":"2314_CR14","doi-asserted-by":"publisher","first-page":"18878","DOI":"10.1038\/s41598-020-75837-5","volume":"10","author":"L Warburton","year":"2020","unstructured":"Warburton L et al (2020) Stopping targeted therapy for complete responders in advanced BRAF mutant melanoma. Sci Rep 10:18878. https:\/\/doi.org\/10.1038\/s41598-020-75837-5","journal-title":"Sci Rep"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02314-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02314-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02314-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:52:00Z","timestamp":1782175920000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-026-02314-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2314"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02314-x","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients or their guardians provided informed consent to participate in the study, which was conducted in accordance with the ethical principles of the Declaration of Helsinki. The study protocol was approved by the Ethics Committee of the Oita University Faculty of Medicine (approval no, 3025).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}